City
Epaper

Study claims ‘Siddha’ drugs combination can reduce anaemia in girls

By IANS | Updated: September 10, 2024 15:25 IST

New Delhi, Sep 10 A combination of Siddha drug treatment can help reduce anaemia among adolescent girls, claims ...

Open in App

New Delhi, Sep 10 A combination of Siddha drug treatment can help reduce anaemia among adolescent girls, claims a study on Tuesday.

The study showed that Siddha drug combination “Annapeticenturam, Bavana katukkay, Matuḷai maṇappaku and Nellikkay lekiyam (ABMN) can improve the level of haemoglobin as well as Packed cell volume (PCV), Mean Corpuscular volume (MCV) and Mean Corpuscular Haemoglobin (MCH) in the anaemic adolescent girls”.

The ABMN medication “significantly lowered the clinical features of anaemia like fatigue, hair loss, headache, loss of interest and menstrual irregularities and significantly improved the level of haemoglobin and PCV, MCV, and MCH in all anaemic girls,” showed the study published in the reputed Indian Journal of Traditional Knowledge (IJTK).

“Siddha medicine plays a notable role in Public Health Initiatives of the Ministry of Ayush. The awareness created among adolescent girls, dietary advice and preventive care provided to them and the treatment through Siddha drugs provided therapeutic benefits to the anaemic patients,” said Dr. R. Meenakumari, Director, National Institute of Siddha, an autonomous body under the Ministry of Ayush.

The study included 2,648 girls, of which 2,300 completed the standard 45-day programme. Reportedly, before the start of the programme, researchers dewormed the participants with Cunṭaivarral curaṇam, and then a 45-day treatment of ABMN was given to all participants under observation.

The team checked for the presence of clinical features like breathlessness, fatigue, giddiness, headache, anorexia, and pallor before and after completion of the programme, along with haemoglobin evaluation and biochemical estimations.

Following the WHO guidelines, the cut-off point for anaemia was set as 11.9 mg/dl, haemoglobin level below 8.0 mg/dl considered as severe, between 8.0 to 10.9 mg/dl as moderate and mild between 11.0 to 11.9 mg/dl.

Further, the team conducted a laboratory investigation for haemoglobin, PCV, MCV, MCH, red blood corpuscles (RBC), platelets, total White blood corpuscles (WBC), neutrophils, lymphocytes and eosinophils in a randomly selected subset of 283 girls.

“Siddha drugs for anaemia can contribute to public health by providing cost-effective and accessible treatment in various settings,” Meenakumari said.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

NationalDelhi Metro fares to rise from today; first hike in eight years

ThaneThane Traffic Update: Heavy Vehicles Banned from Entering Bhiwandi Until Further Orders; Check Details

InternationalIran's supreme leader says US seeks Iran's 'obedience,' rejects direct talks with Washington

InternationalRussian FM Lavrov accuses West, Zelensky of blocking Ukraine peace talks

NationalBulandshahr Accident: 8 Killed, 43 Injured As Truck Hits Tractor-Trolley Carrying Pilgrims in UP

Technology Realted Stories

TechnologyAnurag Thakur’s cosmic curveball sparks lively debate on National Space Day

TechnologyAI a foundational step towards Manipur’s digital governance journey: Officials

TechnologyNTPC to kick off work for new nuclear power plant in Rajasthan next month

TechnologyPC demand remains strong in India as market grows 5.7 pc in Jan-June

Technology45 crore Indians lost Rs 20,000 crore yearly to money games, new Gaming Bill to guide youth